1997
DOI: 10.1097/00001756-199703030-00025
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test

Abstract: The present study demonstrates that local cutaneous administration of either the N-methyl-D-aspartate (NMDA) glutamate receptor antagonist MK-801 or the non-NMDA glutamate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) significantly attenuates formalin-induced nociceptive behaviors. Specifically, pretreatment with either drug reduced the magnitude and time course of lifting and licking behavior in the late phase of formalin pain; however, flinching behavior was not affected. In contrast, post-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
94
0
5

Year Published

1998
1998
2017
2017

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 193 publications
(101 citation statements)
references
References 14 publications
2
94
0
5
Order By: Relevance
“…17 Besides, experimental studies point out that peripherally administered NMDA receptor antagonists are implicated with antinociception. 24 In our study, the maximum occurrence of POST was 51.4% at two hrs in Controls. Occurrence of POST was reduced significantly at four hours in study group compared to Controls.…”
Section: Discussionsupporting
confidence: 47%
“…17 Besides, experimental studies point out that peripherally administered NMDA receptor antagonists are implicated with antinociception. 24 In our study, the maximum occurrence of POST was 51.4% at two hrs in Controls. Occurrence of POST was reduced significantly at four hours in study group compared to Controls.…”
Section: Discussionsupporting
confidence: 47%
“…Loperamide-induced inhibition of voltage-gated calcium channels (Church et al 1994;Hagiwara et al 2003;Reynolds et al 1984) and NMDA receptors (Church et al 1994) present both in CNS and in sensory fibers (Carlton et al 1995;Coggeshall and Carlton 1998;Davidson et al 1997;Kinkelin et al 2000) is broadly consistent with its analgesic properties, considering the well-documented efficacy of selective antagonists of voltage-gated calcium channels and NMDA receptors in treating inflammatory and neuropathic pain symptoms (Chizh and Headley 2005;McGivern 2006). Our finding of loperamide-induced inhibition of HCN channels is also consistent with HCN channels involvement in the pathophysiology of pain (Chaplan et al 2003;Hutcheon and Yarom 2000;Pape 1996;Yao et al 2003).…”
Section: Physiological Significance Of Loperamide-induced I H Inhibitionmentioning
confidence: 99%
“…[25][26][27] Peripheral injection of NMDA receptor antagonist attenuates pain associated with neuropathic or inflammatory origin. [28][29][30][31][32] Thus, the involvements of NMDA receptors are expected in the peripheral processing of nociception.…”
Section: Discussionmentioning
confidence: 99%